1. Home
  2. IMRX vs CNVS Comparison

IMRX vs CNVS Comparison

Compare IMRX & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • CNVS
  • Stock Information
  • Founded
  • IMRX 2008
  • CNVS 2000
  • Country
  • IMRX United States
  • CNVS United States
  • Employees
  • IMRX N/A
  • CNVS N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • CNVS Consumer Electronics/Video Chains
  • Sector
  • IMRX Health Care
  • CNVS Consumer Discretionary
  • Exchange
  • IMRX Nasdaq
  • CNVS Nasdaq
  • Market Cap
  • IMRX 62.7M
  • CNVS 56.2M
  • IPO Year
  • IMRX 2021
  • CNVS 2003
  • Fundamental
  • Price
  • IMRX $2.02
  • CNVS $3.54
  • Analyst Decision
  • IMRX Buy
  • CNVS Buy
  • Analyst Count
  • IMRX 7
  • CNVS 1
  • Target Price
  • IMRX $12.80
  • CNVS $10.00
  • AVG Volume (30 Days)
  • IMRX 4.9M
  • CNVS 104.5K
  • Earning Date
  • IMRX 02-28-2025
  • CNVS 02-12-2025
  • Dividend Yield
  • IMRX N/A
  • CNVS N/A
  • EPS Growth
  • IMRX N/A
  • CNVS N/A
  • EPS
  • IMRX N/A
  • CNVS N/A
  • Revenue
  • IMRX N/A
  • CNVS $45,005,000.00
  • Revenue This Year
  • IMRX N/A
  • CNVS $50.96
  • Revenue Next Year
  • IMRX N/A
  • CNVS N/A
  • P/E Ratio
  • IMRX N/A
  • CNVS N/A
  • Revenue Growth
  • IMRX N/A
  • CNVS N/A
  • 52 Week Low
  • IMRX $1.00
  • CNVS $0.72
  • 52 Week High
  • IMRX $7.68
  • CNVS $4.19
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 47.82
  • CNVS 49.00
  • Support Level
  • IMRX $1.84
  • CNVS $3.34
  • Resistance Level
  • IMRX $3.80
  • CNVS $3.60
  • Average True Range (ATR)
  • IMRX 0.29
  • CNVS 0.23
  • MACD
  • IMRX -0.03
  • CNVS -0.05
  • Stochastic Oscillator
  • IMRX 9.18
  • CNVS 28.57

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Share on Social Networks: